These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2679129)

  • 1. Hepatic glucose output in humans measured with labeled glucose to reduce negative errors.
    Levy JC; Brown G; Matthews DR; Turner RC
    Am J Physiol; 1989 Oct; 257(4 Pt 1):E531-40. PubMed ID: 2679129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fasting on plasma glucose and prolonged tracer measurement of hepatic glucose output in NIDDM.
    Glauber H; Wallace P; Brechtel G
    Diabetes; 1987 Oct; 36(10):1187-94. PubMed ID: 3308588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a variable tracer infusion method to determine glucose turnover in humans.
    Molina JM; Baron AD; Edelman SV; Brechtel G; Wallace P; Olefsky JM
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E16-23. PubMed ID: 2405697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production.
    Ader M; Bergman RN
    Am J Physiol; 1990 Jun; 258(6 Pt 1):E1020-32. PubMed ID: 2193527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constant infusion and bolus injection of stable-label tracer give reproducible and comparable fasting HGO.
    Hovorka R; Eckland DJ; Halliday D; Lettis S; Robinson CE; Bannister P; Young MA; Bye A
    Am J Physiol; 1997 Jul; 273(1 Pt 1):E192-201. PubMed ID: 9252496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Errors inherent in the primed infusion method for the measurement of the rate of glucose appearance in man when uptake is not forced by glucose or insulin infusion.
    Heath DF
    Clin Sci (Lond); 1990 Sep; 79(3):201-13. PubMed ID: 2169367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components.
    Ader M; Ni TC; Bergman RN
    J Clin Invest; 1997 Mar; 99(6):1187-99. PubMed ID: 9077526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated hepatic glucose production in children with cystic fibrosis.
    Kien CL; Horswill CA; Zipf WB; McCoy KS; O'Dorisio T
    Pediatr Res; 1995 May; 37(5):600-5. PubMed ID: 7603777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans.
    Butler PC; Caumo A; Zerman A; O'Brien PC; Cobelli C; Rizza RA
    Am J Physiol; 1993 Apr; 264(4 Pt 1):E548-60. PubMed ID: 8476033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity.
    Efendic S; Karlander S; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1953-61. PubMed ID: 3290257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus.
    Puhakainen I; Koivisto VA; Yki-Järvinen H
    J Clin Endocrinol Metab; 1992 Sep; 75(3):789-94. PubMed ID: 1517368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of chloroquine in patients with non-insulin-dependent diabetes mellitus.
    Powrie JK; Smith GD; Shojaee-Moradie F; Sönksen PH; Jones RH
    Am J Physiol; 1991 Jun; 260(6 Pt 1):E897-904. PubMed ID: 2058666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.
    Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G
    Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of obesity on insulin action in NIDDM.
    Campbell PJ; Carlson MG
    Diabetes; 1993 Mar; 42(3):405-10. PubMed ID: 8432411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose turnover in presence of changing glucose concentrations: error analysis for glucose disappearance.
    Caumo A; Homan M; Katz H; Cobelli C; Rizza R
    Am J Physiol; 1995 Sep; 269(3 Pt 1):E557-67. PubMed ID: 7573434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.
    Turk D; Alzaid A; Dinneen S; Nair KS; Rizza R
    J Clin Invest; 1995 Feb; 95(2):755-62. PubMed ID: 7860757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of hepatic autoregulation after carbohydrate overfeeding in normal man.
    Clore JN; Helm ST; Blackard WG
    J Clin Invest; 1995 Oct; 96(4):1967-72. PubMed ID: 7560089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.